Rajeev Gupta, Neelesh Gupta, Shukri Saliba Shukri Mushahwar and Abdullah Mohammed Shehab
Percutaneous coronary interventions (PCI) have become standard-of-care management of obstructive coronary artery disease (CAD), particularly in acute coronary syndromes (ACS). Only balloon dilation i.e., plain old balloon angioplasty (POBA) despite reducing coronary stenosis and improving symptoms, had unacceptable restenosis rates and at times catastrophic abrupt vessel closure. Bare-metal stent (BMS) was invented to overcome such issues. The improved results with BMS was sensational as it reduced catastrophic abrupt vessel closure and restenosis significantly.
